Author
Listed:
- Agessandro Abrahao
(University of Toronto
University of Toronto
Sunnybrook Research Institute)
- Ying Meng
(University of Toronto
Sunnybrook Research Institute
University of Toronto)
- Maheleth Llinas
(Sunnybrook Research Institute
University of Toronto)
- Yuexi Huang
(University of Toronto)
- Clement Hamani
(University of Toronto
Sunnybrook Research Institute
University of Toronto)
- Todd Mainprize
(University of Toronto)
- Isabelle Aubert
(University of Toronto
University of Toronto)
- Chinthaka Heyn
(University of Toronto
University of Toronto)
- Sandra E. Black
(University of Toronto
University of Toronto
University of Toronto
University of Toronto)
- Kullervo Hynynen
(University of Toronto
University of Toronto
University of Toronto
University of Toronto)
- Nir Lipsman
(University of Toronto
Sunnybrook Research Institute
University of Toronto)
- Lorne Zinman
(University of Toronto
University of Toronto)
Abstract
MR-guided focused ultrasound (MRgFUS) is an emerging technology that can accurately and transiently permeabilize the blood-brain barrier (BBB) for targeted drug delivery to the central nervous system. We conducted a single-arm, first-in-human trial to investigate the safety and feasibility of MRgFUS-induced BBB opening in eloquent primary motor cortex in four volunteers with amyotrophic lateral sclerosis (ALS). Here, we show successful BBB opening using MRgFUS as demonstrated by gadolinium leakage at the target site immediately after sonication in all subjects, which normalized 24 hours later. The procedure was well-tolerated with no serious clinical, radiologic or electroencephalographic adverse events. This study demonstrates that non-invasive BBB permeabilization over the motor cortex using MRgFUS is safe, feasible, and reversible in ALS subjects. In future, MRgFUS can be coupled with promising therapeutics providing a targeted delivery platform in ALS.
Suggested Citation
Agessandro Abrahao & Ying Meng & Maheleth Llinas & Yuexi Huang & Clement Hamani & Todd Mainprize & Isabelle Aubert & Chinthaka Heyn & Sandra E. Black & Kullervo Hynynen & Nir Lipsman & Lorne Zinman, 2019.
"First-in-human trial of blood–brain barrier opening in amyotrophic lateral sclerosis using MR-guided focused ultrasound,"
Nature Communications, Nature, vol. 10(1), pages 1-9, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-12426-9
DOI: 10.1038/s41467-019-12426-9
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-12426-9. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.